NYVRX
Price
$26.90
Change
-$0.21 (-0.77%)
Updated
Aug 15 closing price
Net Assets
6.68B
VIVIX
Price
$70.31
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

NYVRX vs VIVIX

Header iconNYVRX vs VIVIX Comparison
Open Charts NYVRX vs VIVIXBanner chart's image
Davis NY Venture R
Price$26.90
Change-$0.21 (-0.77%)
VolumeN/A
Net Assets6.68B
Vanguard Value Index I
Price$70.31
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
NYVRX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NYVRX vs. VIVIX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NYVRX is a StrongBuy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 196B vs. NYVRX (6.68B). VIVIX pays higher dividends than NYVRX: VIVIX (2.19) vs NYVRX (1.23). NYVRX was incepted earlier than VIVIX: NYVRX (22 years) vs VIVIX (27 years). NYVRX (1.20) is less costly to investors than VIVIX (0.04). NYVRX is a more actively managed with annual turnover of: 17.00 vs. VIVIX (9.00). NYVRX has a lower initial minimum investment than VIVIX: NYVRX (500000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.91 vs. NYVRX (-2.62). VIVIX return over 5 years is better than : 68.54 vs. NYVRX (-0.24).
NYVRXVIVIXNYVRX / VIVIX
Total Expense Ratio1.200.043,000%
Annual Report Gross Expense Ratio1.200.043,000%
Fund Existence22 years27 years-
Gain YTD4.8946.53375%
Front LoadN/AN/A-
Min. Initial Investment500000500000010%
Min. Initial Investment IRAN/AN/A-
Net Assets6.68B196B3%
Annual Yield % from dividends1.232.1956%
Returns for 1 year-2.627.91-33%
Returns for 3 years14.9525.9358%
Returns for 5 years-0.2468.54-0%
Returns for 10 years-19.54114.61-17%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RAGHX26.250.33
+1.27%
Virtus KAR Health Sciences A
TRBCX211.02-0.20
-0.09%
T. Rowe Price Blue Chip Growth
IAUYX28.14-0.13
-0.46%
Invesco Dividend Income Y
GMPPX38.37-0.22
-0.57%
Goldman Sachs Mid Cap Value P
ETNMX14.74-0.09
-0.61%
Eventide Balanced Fund Class N